Immunic, Inc.

SecurityIMUX / Immunic, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership565,645 shares
Latest Disclosed Value $ 627,866
State Street Corp reports 70.40% increase in ownership of IMUX / Immunic, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 565,645 shares of Immunic, Inc. (US:IMUX) valued at $627,866 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 331,945 shares of Immunic, Inc.. This represents a change in shares of 70.40% during the quarter. The current value of the position is $8,162,257 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNIC COM 4525EP101 565,645 233,700 70.40 628 254.24 0.0000
2026-02-13 2025-12-31 13F IMMUNIC COM 4525EP101 331,945 0 0.00 177 -39.38 0.0000
2025-11-14 2025-09-30 13F IMMUNIC COM 4525EP101 331,945 0 0.00 293 26.41 0.0000
2025-08-14 2025-06-30 13F IMMUNIC COM 4525EP101 331,945 28,000 9.21 232 -30.21 0.0000
2025-05-15 2025-03-31 13F IMMUNIC COM 4525EP101 303,945 0 0.00 331 9.24 0.0000
2025-02-14 2024-12-31 13F IMMUNIC COM 4525EP101 303,945 136,800 81.85 304 10.18 0.0000
2024-11-14 2024-09-30 13F IMMUNIC COM 4525EP101 167,145 11,642 7.49 276 59.88 0.0000
2024-08-14 2024-06-30 13F IMMUNIC COM 4525EP101 155,503 25,000 19.16 173 0.00 0.0000
2024-05-15 2024-03-31 13F IMMUNIC COM 4525EP101 130,503 4,700 3.74 172 -8.51 0.0000
2024-02-14 2023-12-31 13F IMMUNIC COM 4525EP101 125,803 0 0.00 189 2.17 0.0000
2023-11-14 2023-09-30 13F IMMUNIC COM 4525EP101 125,803 0 0.00 185 -41.59 0.0000
2023-08-14 2023-06-30 13F IMMUNIC COM 4525EP101 125,803 0 0.00 316 68.45 0.0000
2023-05-15 2023-03-31 13F IMMUNIC COM 4525EP101 125,803 48,600 62.95 187 73.15 0.0000
2023-05-15 2022-12-31 13F/A-99 IMMUNIC COM 4525EP101 77,203 11,300 17.15 108 -48.08 0.0000
2023-05-15 2022-12-31 13F IMMUNIC COM 4525EP101 77,203 11,300 108 0.0000
2022-11-15 2022-09-30 13F IMMUNIC COM 4525EP101 65,903 0 0.00 208 -9.17 0.0000
2022-08-15 2022-06-30 13F IMMUNIC COM 4525EP101 65,903 -253,672 -79.38 229 -93.66 0.0000
2022-05-16 2022-03-31 13F IMMUNIC COM 4525EP101 319,575 -144,425 -31.13 3,611 -18.67 0.0002
2022-02-14 2021-12-31 13F IMMUNIC COM 4525EP101 464,000 23,056 5.23 4,440 13.79 0.0002
2021-11-15 2021-09-30 13F IMMUNIC COM 4525EP101 440,944 89,648 25.52 3,902 -9.40 0.0002
2021-08-16 2021-06-30 13F IMMUNIC COM 4525EP101 351,296 102,277 41.07 4,307 8.52 0.0002
2021-07-09 2021-03-31 13F/A-1 IMMUNIC COM 4525EP101 249,019 162,719 188.55 3,969 200.68 0.0002
2021-05-17 2021-03-31 13F IMMUNIC COM 4525EP101 249,019 162,719 3,969 0.0002
2021-02-16 2020-12-31 13F IMMUNIC COM 4525EP101 86,300 15,675 22.19 1,320 0.61 0.0001
2020-11-10 2020-09-30 13F IMMUNIC COM 4525EP101 70,625 37,265 111.71 1,312 224.75 0.0001
2020-08-14 2020-06-30 13F IMMUNIC COM 4525EP101 33,360 33,360 -52.76 404 -69.21 0.0000
2019-08-14 2019-06-30 13F VITAL THERAPIES COM 92847R104 0 -389,259 -100.00 0 -100.00
2019-05-15 2019-03-31 13F VITAL THERAPIES COM 92847R104 389,259 400 0.10 77 6.94 0.0000
2019-02-12 2018-12-31 13F VITAL THERAPIES COM 92847R104 388,859 -40,777 -9.49 72 -38.98 0.0000
2018-11-09 2018-09-30 13F VITAL THERAPIES Common equity shares 92847R104 429,636 62,124 16.90 118 -95.31 0.0000
2018-08-14 2018-06-30 13F VITAL THERAPIES Common equity shares 92847R104 367,512 333,629 984.65 2,518 994.78 0.0002
2018-05-15 2018-03-31 13F VITAL THERAPIES Common equity shares 92847R104 33,883 3,013 9.76 230 25.00 0.0000
2018-02-14 2017-12-31 13F VITAL THERAPIES Common equity shares 92847R104 30,870 6,970 29.16 184 52.07 0.0000
2017-11-14 2017-09-30 13F VITAL THERAPIES Common equity shares 92847R104 23,900 -42,949 -64.25 121 -37.95 0.0000
2017-08-14 2017-06-30 13F VITAL THERAPIES Common equity shares 92847R104 66,849 -262,162 -79.68 195 -85.20 0.0000
2017-05-15 2017-03-31 13F VITAL THERAPIES Common equity shares 92847R104 329,011 920 0.28 1,318 -7.64 0.0001
2017-02-09 2016-12-31 13F VITAL THERAPIES Common equity shares 92847R104 328,091 18,645 6.03 1,427 -24.54 0.0001
2017-01-13 2016-09-30 13F/A-1 VITAL THERAPIES Common equity shares 92847R104 309,446 4,615 1.51 1,891 0.11 0.0002
2016-11-14 2016-09-30 13F VITAL THERAPIES Common equity shares 92847R104 309,446 1,891
2016-08-12 2016-06-30 13F VITAL THERAPIES Common equity shares 92847R104 304,831 -7,376 -2.36 1,889 -33.32 0.0002
2016-05-20 2016-03-31 13F/A-1 VITAL THERAPIES Common equity shares 92847R104 312,207 47,968 18.15 2,833 -6.90 0.0003
2016-05-12 2016-03-31 13F VITAL THERAPIES Common equity shares 92847R104 312,207 2,833
2016-02-16 2015-12-31 13F VITAL THERAPIES Common equity shares 92847R104 264,239 29,411 12.52 3,043 221.67 0.0003
2015-11-16 2015-09-30 13F VITAL THERAPIES Common equity shares 92847R104 234,828 69,329 41.89 946 -72.91 0.0001
2015-08-13 2015-06-30 13F VITAL THERAPIES Common equity shares 92847R104 165,499 89,252 117.06 3,492 82.45 0.0004
2015-05-15 2015-03-31 13F VITAL THERAPIES Common equity shares 92847R104 76,247 -3,802 -4.75 1,914 -3.82 0.0002
2015-02-11 2014-12-31 13F VITAL THERAPIES Common equity shares 92847R104 80,049 28,660 55.77 1,990 89.70 0.0002
2014-11-12 2014-09-30 13F/A-1 VITAL THERAPIES Common equity shares 92847R104 51,389 6,425 14.29 1,049 -14.30 0.0001
2014-11-10 2014-09-30 13F VITAL THERAPIES Common equity shares 92847R104 51,389 1,049
2014-08-12 2014-06-30 13F VITAL THERAPIES Common equity shares 92847R104 44,964 44,964 1,224 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.